|
|
|
1
|
Childs RW, Barrett J.
Nonmyeloablative allogeneic immunotherapy for solid tumors.
Annu Rev Med 55: 459-75, 2004.
[Text Abstract on PubMed]
|
|
|
2
|
Grube M, Rezvani K, Wiestner A, Fujiwara H, Sconocchia G, Melenhorst JJ, Hensel N, Marti GE, Kwak LW, Wilson W, Barrett JA.
Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.
Clin Cancer Res 10(3): 1047-56, 2004.
[Text Abstract on PubMed]
|
|
|
3
|
Barrett J.
Allogeneic stem cell transplantation for chronic myeloid leukemia.
Semin Hematol 40(1): 59-71, 2003.
[Text Abstract on PubMed]
|
|
|
4
|
Barrett J, Childs R.
New directions in allogeneic stem cell transplantation.
Semin Hematol 39(1): 1-2, 2002.
[Text Abstract on PubMed]
|
|
|
5
|
Barrett J.
The basis of the alloimmune response.
Cytotherapy 4(5): 419-22, 2002.
[Text Abstract on PubMed]
|
|
|
6
|
Hematti P, Sloand EM, Carvallo CA, Albert MR, Yee CL, Fuehrer MM, Blancato JK, Kearns WG, Barrett JA, Childs RW, Vogel JC, Dunbar CE.
Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.
Exp Hematol 30(8): 943-9, 2002.
[Text Abstract on PubMed]
|
|
|
7
|
Maciejewski JP, Risitano AM, Sloand EM, Wisch L, Geller N, Barrett JA, Young NS, Ristiano AM.
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome.
Br J Haematol 117(1): 119-26, 2002.
[Text Abstract on PubMed]
|
|
|
8
|
Magnusson MK, Meade KE, Nakamura R, Barrett J, Dunbar CE.
Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene.
Blood 100(3): 1088-91, 2002.
[Text Abstract on PubMed]
|
|
|
9
|
Stroncek D, Harvath L, Barrett J.
National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation.
Cytotherapy 4(5): 415-8, 2002.
[Text Abstract on PubMed]
|
|
|
10
|
Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie EJ.
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.
Antimicrob Agents Chemother 45(12): 3487-96, 2001.
[Text Abstract on PubMed]
|
|
|
11
|
Barrett J, Childs R.
Non-myeloablative stem cell transplants.
Br J Haematol 111(1): 6-17, 2000.
[Text Abstract on PubMed]
|
|
|
12
|
Barrett J.
Myelodysplastic syndrome and aplastic anemia--diagnostic and conceptual uncertainties.
Leuk Res 24(7): 595-6, 2000.
[Text Abstract on PubMed]
|
|
|
13
|
Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J, Young NS.
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.
Blood 95(7): 2269-74, 2000.
[Text Abstract on PubMed]
|
|
|
14
|
Cheson BD, Vena DA, Barrett J, Freidlin B.
Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
J Clin Oncol 17(8): 2454-60, 1999.
[Text Abstract on PubMed]
|
|
|
15
|
Childs R, Epperson D, Bahceci E, Clave E, Barrett J.
Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect.
Br J Haematol 107(2): 396-400, 1999.
[Text Abstract on PubMed]
|
|
|
16
|
Childs RW, Clave E, Tisdale J, Plante M, Hensel N, Barrett J.
Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.
J Clin Oncol 17(7): 2044-9, 1999.
[Text Abstract on PubMed]
|
|
|
17
|
Cheson BD, Sorensen JM, Vena DA, Montello MJ, Barrett JA, Damasio E, Tallman M, Annino L, Connors J, Coiffier B, Lauria F.
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.
J Clin Oncol 16(9): 3007-15, 1998.
[Text Abstract on PubMed]
|
|
|
18
|
Jiang YZ, Barrett J.
The allogeneic CD4+ T-cell-mediated graft-versus-leukemia effect.
Leuk Lymphoma 28(1-2): 33-42, 1997.
[Text Abstract on PubMed]
|
|
|
19
|
Barrett J, Malkovska V.
The graft-versus-leukemia effect.
Curr Opin Oncol 8(2): 89-95, 1996.
[Text Abstract on PubMed]
|
|
|
20
|
Mavroudis D, Barrett J.
The graft-versus-leukemia effect.
Curr Opin Hematol 3(6): 423-9, 1996.
[Text Abstract on PubMed]
|
|
|
21
|
Barrett JA.
Strategies to enhance the graft-versus-malignancy effect in allogeneic transplants.
Ann N Y Acad Sci 770: 203-12, 1995.
[Text Abstract on PubMed]
|
|
|
22
|
Burt RK, Burns W, Ruvolo P, Fischer A, Shiao C, Guimaraes A, Barrett J, Hess A.
Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis.
J Neurosci Res 41(4): 526-31, 1995.
[Text Abstract on PubMed]
|
|
|
23
|
Barrett J.
The molecular basis of graft-versus-leukemia in CML.
Bone Marrow Transplant 14 Suppl 3: S68-73, 1994.
[Text Abstract on PubMed]
|
|
|
24
|
Schoenlein PV, Shen DW, Barrett JT, Pastan I, Gottesman MM.
Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB carcinoma cells.
Mol Biol Cell 3(5): 507-20, 1992.
[Text Abstract on PubMed]
|
|
|
25
|
Barrett JT, Orofiamma B, Khandekar JD, Carbone PP, Comis RL, Davis TE.
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract.
Cancer 64(12): 2445-7, 1989.
[Text Abstract on PubMed]
|
|
|
26
|
Hoshino T, Jiang YZ, Dunn D, Paul D, Qazilbash M, Cowan K, Wang J, Barrett J, Liu J.
Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination.
Cancer Gene Ther 5(3): 150-7,
[Text Abstract on PubMed]
|
|
|